Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.
Read Full NewsPaul Melmeyer, MPP, executive vice president, public policy and advocacy, Muscular Dystrophy Association, explains how adding Duchenne muscular dystrophy to the Recommended Unified Screening Panel reshapes early diagnosis, treatment timing, and family counseling.
The HCPFive: Top News for Healthcare Providers from the Week of 01/11
1.
WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research
2.
Loneliness and social isolation linked to heightened risk of death in those with cancer
3.
Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.
4.
A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.
5.
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma
1.
Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers
2.
Managing Hematoma: A Guide to Prevention and Treatment
3.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
4.
Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection
5.
What You Need To Know About Trametinib: A Miracle Cancer Treatment?
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
5.
Thromboprophylaxis In Medical Settings
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge